Providence Holy Cross Medical Center is the first Providence hospital in the San Fernando Valley to offer a minimally ...

GSK agreed a worldwide exclusive license agreement for a respiratory disease treatment with Empirico. The U.K. pharmaceutical giant on Tuesday said that as part of the agreement it will make an $85 ...

MISSISSAUGA, ON, Oct. 21, 2025 /CNW/ - Dalhousie University, in collaboration with Nova Scotia Health's INSPIRED COPD ...

For healthy adults, a sore or scratchy throat after a heavy air-pollution day is usually temporary and improves in days with ...

A new clinic led by Dal and community partners — with funding from GSK Canada — will offer faster, community-based ...

Dd you know estrogen and progesterone have a bearing on the nature of the female lung reaction to disease and to ...

A University of Alberta research team is shedding much-needed light on cancer cachexia, a severe muscle-wasting syndrome ...

Chronic obstructive pulmonary disease (COPD) treatments involving inhaled corticosteroids (ICSs) were associated with a greater risk for fractures, a meta-analysis of several dozen randomized trials ...

Dedicated COPD respiratory therapists can improve inhaler use, ensure adherence, and bridge care transitions, explained Megan ...

AstraZeneca's hopes of a big new indication for respiratory drug Fasenra in chronic obstructive pulmonary disease (COPD) have been dashed by a negative phase 3 trial. The RESOLUTE study of IL-5 ...

Exercise reprograms molecular pathways in the body, offering new clues for future disease prevention and treatment. For years, it has been well established that regular exercise builds strength, ...